Clinical observation on the efficacy of non-lactating mastitis treated with staged surgery

doi:10.16139/j.1007-9610.2024.05.13

Abstract

Abstract:

Objective To explore the clinical efficacy of staged surgery for non-lactating mastitis. Methods A retrospective analysis was conducted on 317 patients with non-lactating mastitis admitted to our department from January 2015 to December 2020, all of whom underwent staged surgical treatment. The recovery time, recurrence rate, and breast appearance score were observed. Results The median follow-up time was 24(17，33) months, the recovery time was (25.5±17.9) days, and the recurrence rate was 4.4%. There were 96.2% of patients satisfied with the breast appearance. Conclusions Staged surgery for non-lactating mastitis can effectively shorten the course of the disease, protect the appearance of breast, and have good clinical efficacy.

Key words: Staged surgery, Non-lactating mastitis, Recovery time, Recurrence rate

CLC Number:

R655.8

QU Wenchao, WAN Hua, WU Xueqing, FENG Jiamei, XIE Lu, GAO Qingqian, SHAO Shijun, SUN Jiaye. Clinical observation on the efficacy of non-lactating mastitis treated with staged surgery[J]. Journal of Surgery Concepts & Practice, 2024, 29(05): 446-451.

Figures/Tables 3

References 23

[1]	胡玥, 奚佩雯, 石靓, 等. 非哺乳期乳腺炎的分类和诊治进展[J]. 南京医科大学学报(自然科学版), 2019, 39(5):769-773.
	HU Y, XI P W, SHI L, et al. Advances in the classification,diagnosis and treatment of non-puerperal mastitis[J]. J Nanjing Med Univ(Nat Sci), 2019, 39(5):769-773.
[2]	国家中医药管理局医政司. 中医病症诊断疗效标准[M]. 北京: 中国中医药出版社,2017:132-133.
	Medical Affairs Department of the National Administration of Traditional Chinese Medicine. Diagnostic and therapeutic standards for traditional Chinese medicine diseases[M]. Beijing: China Traditional Chinese Medicine Press,2017:132-133.
[3]	刘璐. 非哺乳期乳腺炎病因学及临床治疗初步探讨[D]. 山东: 山东大学, 2017.
	LIU L. The investigation of the etiology and antituberculous therapy for non-puerperal mastitis[D]. Shandong: Shandong University, 2017.
[4]	SHIN H R, JOUBERT C, BONIOL M, et al. Recent trends and patterns in breast cancer incidence among Eastern and Southeastern Asian women[J]. Cancer Causes Control, 2010, 21(11):1777-1785.
[5]	王森. 非哺乳期乳腺炎手术治疗疗效评估[J]. 中国继续医学教育, 2020, 12(12):105-106.
	WANG S. Evaluation of curative effect of non-lactating mastitis[J]. China Contin Med Educ, 2020, 12(12):105-106.
[6]	林建山, 郑剑忠, 黄冬凌, 等. 不同方法治疗肉芽肿性小叶性乳腺炎的对比研究[J]. 局解手术学杂志, 2015(1):58-59,60.
	LIN J S, ZHENG J Z, HIANG D L. Comparative study of the treatment of granulomatous lobular mastitis by different methods[J]. J Reg Anat Oper Surg, 2015(1):58-59,60.
[7]	PAZ M E P, LAZO L B, PALAO D C, et al. Efficacy and safety of oncoplastic surgery plus drug therapy for chronic tuberculous granulomatous mastitis[J]. Int J Tuberc Lung Dis, 2020, 24(6):585-590. doi: 10.5588/ijtld.19.0478 pmid: 32553002
[8]	杨帆. 糖皮质激素与手术在肉芽肿性乳腺炎治疗中的应用分析[J]. 北方药学, 2019, 16(9):116-117.
	YANG F. Analysis of the application of glucocorticoids and surgery regimen in granulomatous mastitis[J]. J North Pharm, 2019, 16(9):124-125.
[9]	中华预防医学会妇女保健分会乳腺保健与乳腺疾病防治学组. 非哺乳期乳腺炎诊治专家共识[J]. 中国实用外科杂志, 2016, 36(7):755-758.
	The Breast Health and Breast Disease Prevention and Treatment Group of the Women's Health Branch of the Chinese Preventive Medicine Association. Expert consensus on the diagnosis and treatment of non lactating mastitis[J]. Chin J Pract Surg, 2016, 36(7):755-758.
[10]	傅少梅, 殷初阳, 宋晖. 非哺乳期乳腺炎术后即刻假体植入乳房再造术的临床应用[J]. 中国临床医学, 2016, 23(3):315-318.
	FU S M, YIN C Y, SONG H. Application of immediate breast reconstruction with implants after nipple-areola complex-sparing subcutaneous mastectomy for nonpuerperal mastitis[J]. Chin J Clin Med, 2016, 23(3):315-318.
[11]	王刚, 高岭, 刘伟, 等. 微创旋切联合中药治疗肉芽肿性乳腺炎40例[J]. 中国中西医结合外科杂志, 2019, 25(5):819-821.
	WANG G, GAO L, LIU W, et al. Minimally invasive circumcision combined with traditional Chinese medicine for the treatment of 40 cases of granulomatous mastitis[J]. Chin J Surg Integr Tradit Western Med, 2019, 25(5):819-821.
[12]	于琦, 王钢乐. 非哺乳期乳腺炎的临床诊治研究[J]. 临床外科杂志, 2019, 27(3):201-203.
	YU Q, WANG G L. Evaluation on diagnosis and treatment of nonpuerperal mastitis[J]. J Clin Surg, 2019, 27(3):201-203.
[13]	TAHMASEBI S, KARAMI M Y, MAALHAGH M. Granulomatous mastitis: time to introduce new weapons[J]. World J Surg, 2016, 40(11):2827-2828. pmid: 26920409
[14]	CHAN S W, CHEUNG P S, LAM S H. Cosmetic outcome and percentage of breast volume excision in oncoplastic breast conserving surgery[J]. World J Surg, 2010, 34(7):1447-1452. doi: 10.1007/s00268-009-0278-x pmid: 19936979
[15]	韩思佳, 金晓明, 刘臻, 等. 类固醇激素治疗后手术切除与直接扩大切除治疗肉芽肿性小叶性乳腺炎的对比分析[J]. 中华乳腺病杂志(电子版), 2018, 12 (6):373-375.
	HAN S J, JIN X M, LIU Z, et al. Comparative analysis of surgical resection and direct expanded resection for granulomatous lobular mastitis after steroid hormone therapy[J]. Chin J Breast Dis (Electronic Edition), 2018, 12(6):373-375.
[16]	CHIRAPPAPHA P, THAWEEPWORADEJ P, SUPSAMUTCHAI C, et al. Idiopathic granulomatous mastitis: a retrospective cohort study between 44 patients with different treatment modalities[J]. Ann Med Surg(Lond), 2018,36:162-167.
[17]	HLADIK M, SCHOELLER T, ENSAT F, et al. Idiopathic granulomatous mastitis: successful treatment by mastectomy and immediate breast reconstruction[J]. J Plast Reconstr Aesthet Surg, 2011, 64(12):1604-1607. doi: 10.1016/j.bjps.2011.07.011 pmid: 21813343
[18]	YAU F M, MACADAM S A, KUUSK U, et al. The surgical management of granulomatous mastitis[J]. Ann Plast Surg, 2010, 64(1):9-16. doi: 10.1097/SAP.0b013e3181a20cae pmid: 20023450
[19]	孟畑, 程亦勤, 仇闻群, 等. 顾氏外科综合外治法治疗120例粉刺性乳痈的临床研究[J]. 中华中医药杂志, 2021, 36(6):3728-3731.
	MENG T, CHENG Y Q, QIU W Q, et al. Clinical study on the treatment of 120 cases of acne mastoid carbuncle with GUs’ surgery comprehensive external therapy[J]. China J Tradit Chin Med Pharm, 2021, 36(6):3728-3731.
[20]	ANDERSON B O, MASETTI R, SILVERSTEIN M J. Oncoplastic approaches to partial mastectomy: an overview of volume-displacement techniques[J]. Lancet Oncol, 2005, 6(3):145-157. doi: 10.1016/S1470-2045(05)01765-1 pmid: 15737831
[21]	杜峰. 腺体瓣成型法在乳腺区段切除术中的应用研究[J]. 重庆医学, 2014(11):1376-1377.
	DU F. Research on the application of gland flap forming method in breast segmental resection[J]. Chongqing Med J, 2014(11):1376-1377.
[22]	潘红英, 石欣. 乳腺癌保乳手术联合乳晕切口自体组织瓣Ⅰ期乳腺成形近期形态学观察[J]. 中国肿瘤外科杂志, 2016, 8(3):158-162.
	PAN H Y, SHI X. Recent morphological observations on breast-conserving surgery combined with autologous tissue flap-based phase Ⅰ breast morphogenesis via areolar incision in the treatment of breast cancer[J]. Chin J Surg Oncol, 2016, 8(3):158-162.
[23]	邓丁梅, 曹茵, 王西跃. 残留腺体转位整形法在乳腺癌保乳手术中的临床效果[J]. 中国现代普通外科进展, 2017, 20(2):89.
	DENG D M, CAO Y, WANG X Y. Clinical effect of residual gland transposition plastic surgery in breast conserving surgery for breast cancer[J]. Chin J Curr Adv Gen Surg, 2017, 20(2):89.

Symptoms and signs	Degree	Number
Nipple inversion	Yes	153(48.3)
Nipple inversion	No	164(51.7)
Lesion scope	1 quadrant	124(39.1)
	2 quadrant	127(40.1)
	≥3 quadrant	66(20.8)
Skin discolorization	No	80(25.2)
	1 quadrant	113(35.6)
	2 quadrant	94(29.7)
	≥3 quadrant	30(9.5)
Abscess formation	No	21(6.6)
	Unruptured	163(51.4)
	Ruptured	124(39.1)
	Repeated rupture	9(2.8)
Sinus formation	No	184(58.0)
	1 sinus	107(33.8)
	2 sinus	17(5.4)
	3 sinus	9(2.8)
Pain	No	34(10.7)
Pain	Yes	283(89.3)
Stage	Lump stage	25(7.9)
	Abscess stage	161(50.8)
	Fistula stage	131(41.3)
Erythema nodosum	No	301(95.0)
Erythema nodosum	Yes	16(5.0)

Factors	Standardization coefficient β	t value	P value
Age	0.034	0.822	0.412
Postoperative time	0.265	6.24	0.001
Healing time	0.012	0.291	0.771
Lesion scope	0.009	0.185	0.853
Number of sinus	-0.668	-15.976	0.001
Recurrence	-0.066	-1.57	0.117